218.

219,

220.
221,

222.

223.

224.

225.

226.

227.

228.

229,

230.

231.

Deutsch, S.L, Halperin, R., Stanley, M., and Davis, K.L: Effeet of chronic
haloperidol and quinacrine eodadministration on striatal HVA levels on
stereotypie behaviors in response to apomorphine in the rat.
Neurochemical Research 10:491-498, 1985.

Keefe, R.S.E., Mohs, R.C., Losonezy, M.F., Davidson, M., Silverman, J.M.,
Kendler, K.S., Horvath, T.B., Nora, R., and Davis, K.L.: Characteristics of
very poor outcome schizophrenia (in review).

Sherma, R. and Davis, K.L.: Treatment of memory disorders (in press).

Davidson, M., Kendier, K.S., Davis, B.M., Horvath, T.B., Mohs, R.C., and
Davis, K.L.: Apomorphine has no effect on plasma homovanillic acid in
schizophrenic patients. Psychiatry Research 16:95-99, 1985.

Davidson, M., Mohs, R.C., Kendler, K.S., Davis, B,, Johns, C.A., Hollander, E.,
Horvath, T,.B., and Davis, K.L.: Plasma homovanillic acid concentrations in
schizophrenic patients. Biomedicine & Pharmacotherapy (in press).

Davidson, M., Mohs, R.C., Hollander, E., Davis, B.M., Ryan, T., Horvath, T.B.
and Davis, K.L. Physostigmine in patients with Alzheimer's disease

Psychopharmacol Bull 22 (1):101-105, 1986.

Hollander, E., Mohs, R.C., and Davis, K.L.: Cholinergic approaches to the
treatment of Alzheimer's disease. British Medical Bulletin 42:97-100, 1986.

Haroutunian, V.H., Kanof, P.D., and Davis, K.L.: Partial reversal of lesion
induced deficits in cortical cholinergic markers by nerve growth factor.
Brain Res (in press).

Haroutunian, V.H., Kanof, P.D., and Davis, K.L: Partial behavioral,
histochemical restoration of fimbria/fornix lesion induced deficits by septal
transplants (in review).

Haroutunian, V.H., Davis, K.L., Davis, B.M., Horvath, T.B., Johns, C.A. and
Mohs, R.C.: The study of cholinomimeties in Alzheimer's disease and animal

models. In: Psychopharmacology: Recent Advances and Future Prospects,
8.D. Iversen (ed.}, pp. 170-181, Oxford Publications, 1985.
Rosen, W.G., Mohs, R.C., and Davis, K.L.: Assessing symptom severity in

Alzheimer's disease. In: Interdisciplinary Topies in
Gerontology, F. Clifford Rose (ed.) Karger: Basel, 1985, pp. 35-42.

Mohs, R.C., Davis, B.M., Mathe, A.A., Rosen, W.G., Johns, C.A,, Greenwald,
B.S. Horvath, T.B., and Davis, K.L. Intravenous and oral physostigmine in

Alzheimer's disease. In: H.P. Von Hahn (ed.) Interdisciplinary Topics in
Gerontology, Karger: Basel, 1985, pp. 141-152.

Kanof, P., Johns, C.A., Davidson, M., Siever, L.J., Cocearo, EF, and Davis,
K.L.: Prostaglandin receptor sensitivity in psychiatric disorders Arch. Gen.

Psychiatry (in press).
Davis, K.L, Fiori, M., Davis, B.M., Mohs, R.C., Horvath, T.B., and Davidson,

M.: Dopaminergic dysregulation in schizophrenia. Drug Development
Research (in press).

21

 

50287572